A detailed history of Harvest Group Wealth Management, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Harvest Group Wealth Management, LLC holds 156 shares of FOLD stock, worth $1,510. This represents 0.0% of its overall portfolio holdings.

Number of Shares
156
Previous 156 -0.0%
Holding current value
$1,510
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 27, 2023

BUY
$9.89 - $12.7 $158 - $203
16 Added 11.43%
156 $1,000
Q3 2022

Nov 08, 2022

BUY
$9.82 - $12.75 $49 - $63
5 Added 3.7%
140 $2,000
Q2 2022

Aug 04, 2022

BUY
$6.23 - $11.12 $467 - $833
75 Added 125.0%
135 $1,000
Q1 2022

Apr 21, 2022

BUY
$7.89 - $12.48 $473 - $748
60 New
60 $1,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.72B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Harvest Group Wealth Management, LLC Portfolio

Follow Harvest Group Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Group Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Group Wealth Management, LLC with notifications on news.